Drugs / Akatinol Memantine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03986424 Comparator | Jan 2018 → Jun 2022 | vascular dementia | Merz Pharmaceuticals GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Akatinol Memantine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03986424 ↗ |
| Route | Oral | “to be taken orally, once daily” NCT03986424 ↗ |